A new trading day began on Friday, with Edwards Lifesciences Corp (NYSE: EW) stock price down -0.39% from the previous day of trading, before settling in for the closing price of $71.19. EW’s price has ranged from $58.93 to $96.12 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 4.94% over the past five years. Meanwhile, its annual earnings per share averaged 0.94%. With a float of $574.31 million, this company’s outstanding shares have now reached $588.60 million.
Let’s look at the performance matrix of the company that is accounted for 15800 employees. In terms of profitability, gross margin is 78.39%, operating margin of 26.37%, and the pretax margin is 27.76%.
Edwards Lifesciences Corp (EW) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Edwards Lifesciences Corp is 1.95%, while institutional ownership is 87.49%. The most recent insider transaction that took place on Mar 26 ’25, was worth 797,267. In this transaction CVP, Chief Financial Officer of this company sold 11,250 shares at a rate of $70.87, taking the stock ownership to the 30,387 shares. Before that another transaction happened on Mar 26 ’25, when Company’s Officer proposed sale 22,500 for $70.87, making the entire transaction worth $1,594,534.
Edwards Lifesciences Corp (EW) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.62 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.94% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.41% during the next five years compared to -2.36% drop over the previous five years of trading.
Edwards Lifesciences Corp (NYSE: EW) Trading Performance Indicators
Here are Edwards Lifesciences Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.45. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.26. Likewise, its price to free cash flow for the trailing twelve months is 143.28.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.45, a number that is poised to hit 0.60 in the next quarter and is forecasted to reach 2.75 in one year’s time.
Technical Analysis of Edwards Lifesciences Corp (EW)
Edwards Lifesciences Corp (NYSE: EW) saw its 5-day average volume 4.16 million, a negative change from its year-to-date volume of 4.55 million. As of the previous 9 days, the stock’s Stochastic %D was 62.45%. Additionally, its Average True Range was 1.57.
During the past 100 days, Edwards Lifesciences Corp’s (EW) raw stochastic average was set at 50.84%, which indicates a significant decrease from 72.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 13.66% in the past 14 days, which was lower than the 24.94% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $71.37, while its 200-day Moving Average is $72.57. Nevertheless, the first resistance level for the watch stands at $71.50 in the near term. At $72.10, the stock is likely to face the second major resistance level. The third major resistance level sits at $72.53. If the price goes on to break the first support level at $70.47, it is likely to go to the next support level at $70.04. The third support level lies at $69.44 if the price breaches the second support level.
Edwards Lifesciences Corp (NYSE: EW) Key Stats
With a market capitalization of 41.54 billion, the company has a total of 587,865K Shares Outstanding. Currently, annual sales are 5,440 M while annual income is 4,175 M. The company’s previous quarter sales were 1,101 M while its latest quarter income was 385,600 K.
